University of Arkansas for Medical Sciences · BiologyHPV Immunotherapy and Vaccine Development Unit
Mayumi Nakagawa · Little Rock, Arkansas
Research Focus
Dr. Mayumi Nakagawa's lab focuses on developing innovative therapeutic vaccines to enhance immune responses against high-risk human papillomaviruses (HPV), which are responsible for several cancers including cervical and head and neck cancers. The lab is actively conducting clinical trials to evaluate the safety and effectiveness of PepCan, a vaccine designed to boost T-cell responses in patients with HPV-related lesions and cancers. Their research aims to provide alternative treatments that are safer for women who want to preserve their fertility while effectively targeting HPV-related diseases.
HPVtherapeutic vaccineT-cell responsescancer immunotherapyclinical trials
Research Aims
3AIM 01Develop therapeutic vaccines targeting HPV to reduce cancer recurrence.
AIM 02Investigate immune factors influencing responses to the HPV vaccine.
AIM 03Explore the roles of microbiomes in vaccine efficacy.
Skills the Lab Values
clinical trial managementimmune profilingT-cell activation assaysvaccine formulationflow cytometry
Output against the department
Publications143top 48% of dept.494th of 1,033
this lab
most publishedleast published
Citations2.8kbottom 20% of dept.824th of 1,033
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.